These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34602415)

  • 1. MicroRNA-26a systemic administration attenuates tumor formation in hepatocellular carcinoma mouse model.
    Badr AM; El-Ahwany E; Goda L; Nagy F; Helal N; El Deeb S
    Pak J Pharm Sci; 2021 May; 34(3):925-932. PubMed ID: 34602415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
    El-Ahwany E; Mansy SS; Zoheiry M; Mourad L; Mahmoud S; Abu-Taleb H; Hassanien M; Hassan M
    Ultrastruct Pathol; 2020 Mar; 44(2):203-210. PubMed ID: 32216509
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.
    Chen L; Zheng J; Zhang Y; Yang L; Wang J; Ni J; Cui D; Yu C; Cai Z
    Mol Ther; 2011 Aug; 19(8):1521-8. PubMed ID: 21610700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.
    Ette AI; Ndububa DA; Adekanle O; Ekrikpo U
    Niger J Clin Pract; 2017 Oct; 20(10):1267-1272. PubMed ID: 29192630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
    Li SQ; Wang DM; Zhu S; Ma Z; Li RF; Xu ZS; Han HM
    Hum Exp Toxicol; 2015 Nov; 34(11):1053-72. PubMed ID: 25585999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of vitamin K1 on AFP and DCP levels in patients with unresectable HCC and in HCC cell lines.
    Carr BI; Wang Z; Wang M; Wei G
    Dig Dis Sci; 2011 Jun; 56(6):1876-83. PubMed ID: 21188521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
    Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
    J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
    Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
    Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Des-gamma-carboxyprothrombin for early identification and prognosis of hepatocellular carcinoma--a case control study from western Nepal.
    Mittal A; Gupta SP; Sathian B; Sreedharan J; Poudel B; Yadav SK; Pandeya DR
    Asian Pac J Cancer Prev; 2012; 13(11):5773-5. PubMed ID: 23317255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis.
    Zhang L; Hu J; Hao M; Bu L
    Biol Chem; 2020 Feb; 401(3):407-416. PubMed ID: 31318685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
    Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
    Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
    Kodama K; Kawaoka T; Namba M; Uchikawa S; Ohya K; Morio K; Nakahara T; Murakami E; Yamauchi M; Hiramatsu A; Imamura M; Chayama K; Aikata H
    Oncology; 2019; 97(2):75-81. PubMed ID: 31242488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis.
    Zimmers TA; Jin X; Gutierrez JC; Acosta C; McKillop IH; Pierce RH; Koniaris LG
    J Cancer Res Clin Oncol; 2008 Jul; 134(7):753-9. PubMed ID: 18210153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnane X receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F
    Shi T; Fan QY; Liu SB; Zhang SY
    Biochem Pharmacol; 2024 Jul; 225():116309. PubMed ID: 38788959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.